Apjohn Ventures


Early-stage venture capital fund investing in life sciences companies, primarily in the U.S. Midwest. Provides equity financing from seed through Series rounds, deal syndication, technical and clinical due diligence, board-level and operational support, and access to advisors with corporate finance and industry operational experience to advance portfolio companies toward exits (M&A or IPO).

Industries

finance
financial-services
venture-capital-b37d

Nr. of Employees

small (1-50)

Apjohn Ventures

350 E. Michigan Ave, Suite 500, Kalamazoo, MI 49007

Expertise Areas

  • Early-stage venture investing in life sciences
  • Scientific and technical due diligence
  • Clinical development strategy
  • Regulatory advisory and readiness
  • Show More (6)

Key Technologies

  • Oligonucleotide therapeutics
  • Liposomal nanoparticle delivery systems
  • Enzyme replacement therapies
  • Drug-eluting stent delivery and bioabsorbable carriers
  • Show More (2)

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.